<DOC>
	<DOC>NCT01227395</DOC>
	<brief_summary>The investigation will be conducted for the purpose of determining the condition of occurrence of Adverse Events under the actual post-marketing use of Zithromac 600mg Tablet, verifying the therapeutic effects, detecting unknown Adverse Drug Reactions and drug interactions and determining the factors affecting safety and efficacy.</brief_summary>
	<brief_title>Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients</brief_title>
	<detailed_description>All the patients whom an investigator prescribes the first Zithromac Tablets 600mg should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Patients need to be administered Zithromac Tablets 600mg in order to be enrolled in the surveillance. Patients not administered Zithromac Tablets 600mg.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>HIV</keyword>
	<keyword>Post Marketing Surveillance</keyword>
</DOC>